1. 1. “Administer” has the same meaning as in A.R.S. § 32-1901.
2. 2. “Comity” means the procedure for granting an Arizona license to an applicant who is licensed as a podiatrist in another state of the United States.
3. 3. “Controlled substance” has the same meaning as in A.R.S. § 32-1901.
4. 4. “Council” means the Council of Podiatric Medical Education, an organization approved by the American Podiatric Medical Association to govern podiatric education.
5. 5. “Credit hour” means 60 minutes of participation in continuing education.
6. 6. “Day” means calendar day.
7. 7. “DEA” means The Drug Enforcement Administration in the Department of Justice
8. 8. “DEA Registration” means the DEA Controlled Substance Registration required and permitted by 21 U.S.C. 823 of the Controlled Substances Act.
9. 9. “Device” has the same meaning as in A.R.S. § 32-1901 and includes a prescription-only device defined in A.R.S. § 32-1901.
10. 10. “Directly supervise” has the same meaning as “direct supervision” in A.R.S. § 32-871(D).
11. 11. “Dispense” has the same meaning as in A.R.S. § 32-871(F).
12. 12. “Distributor” has the same meaning as in A.R.S. § 32-1901.
13. 13. “Drug” has the same meaning as in A.R.S. § 32-1901 and includes a controlled substance, a narcotic drug defined in A.R.S. § 32-1901, a prescription medication, and a prescription-only drug.

14. 14. “Informed consent” means a document signed by a patient or patient’s representative that authorizes treatment to the patient after the treating podiatrist informs the patient or the patient’s representative of the following:

    1. a. A description of the treatment;
    2. b. A description of the expected benefits of the treatment;
    3. c. Alternatives to the treatment;
    4. d. Associated risks of the treatment, including potential side effects and complications; and
    5. e. The patient’s right to withdraw authorization for the treatment at any time.
15. 15. “Party” has the same meaning as in A.R.S. § 41-1001.
16. 16. “Patient” means an individual receiving treatment from a podiatrist.
17. 17. “Prescription medication” has the same meaning as in A.R.S. § 32-1901.
18. 18. “Prescription-only device” has the same meaning as in A.R.S. § 32-1901.
19. 19. “Prescription-only drug” has the same meaning as in A.R.S. § 32-1901.
20. 20. “Prescription order” has the same meaning as in A.R.S. § 32-1901.
21. 21. “Regular podiatry license” means a license issued pursuant to the provisions of A.R.S. § 32-826(A).
22. 22. “Representative” means a legal guardian, an individual acting on behalf of another individual under written authorization from the individual, or a surrogate according to A.R.S. § 36-3201.
23. 23. “Treatment” means podiatric medical, surgical, mechanical, manipulative, or electrical treatment according to A.R.S. § 32-801.

The following definitions apply in this Chapter unless otherwise specified:

Historical Note

Former Section R4-25-06 renumbered and amended as Section R4-25-01 effective August 30, 1978 (Supp. 78-4). Amended effective April 3, 1980 (Supp. 80-2). Former Section R4-25-01 renumbered and amended as Section R4-25-101 effective November 18, 1986 (Supp. 86-6). Amended effective July 27, 1995 (Supp. 95-3). Amended by final rulemaking at 5 A.A.R. 1000, effective March 16, 1999 (Supp. 99-1). Amended by final rulemaking at 9 A.A.R. 1846, effective July 19, 2003 (Supp. 03-2). Amended by final rulemaking at 26 A.A.R. 1501, effective September 6, 2020 (Supp. 20-3). Amended by final rulemaking at 29 A.A.R. 1551 (July 14, 2023), effective August 18, 2023 (Supp. 23-2).